Alcami Corporation
A Principal Scientist II at Alcami drives pharmaceutical product development through hands-on mass spectrometry testing to identify trace compounds leaching from manufacturing components. This role involves leading method development and validation projects while ensuring GMP compliance and supporting patient safety through rigorous analytical data interpretation. The scientist collaborates with clients on audits and technical discussions within a fast-paced, regulated environment.
Headquarters
Wilmington, North Carolina, United States
Company Size
501-1000 employees
Founded
1979
Alcami Corporation is a global contract development and manufacturing organization (CDMO) headquartered in North Carolina with over 45 years of experience advancing pharmaceuticals and biologics from development to delivery. The company offers three core service pillars: drug product manufacturing (including sterile fill-finish and oral solid dose), laboratory services (analytical and microbiological testing), and cGMP pharmaceutical storage and support services (including calibration, validation, environmental monitoring, and equipment rentals). Alcami serves pharma and biotech companies across the full development-to-commercial supply continuum and is backed by private equity investors GHO Capital, The Vistria Group, and Ampersand Capital Partners.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Alcami Corporation.
109% above the average for this role